These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30950333)

  • 1. Recent In Silico Research in High-Throughput Drug Discovery and Molecular Biochemistry.
    Zhang J; Chai H
    Curr Top Med Chem; 2019; 19(2):103-104. PubMed ID: 30950333
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of in silico screening in the discovery of novel and safer drug candidates.
    Rognan D
    Pharmacol Ther; 2017 Jul; 175():47-66. PubMed ID: 28223231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications and limitations of in silico models in drug discovery.
    Sacan A; Ekins S; Kortagere S
    Methods Mol Biol; 2012; 910():87-124. PubMed ID: 22821594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ecstasy and Agony of Assay Interference Compounds.
    Aldrich C; Bertozzi C; Georg GI; Kiessling L; Lindsley C; Liotta D; Merz KM; Schepartz A; Wang S
    J Med Chem; 2017 Mar; 60(6):2165-2168. PubMed ID: 28244745
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent trends and future prospects in computational GPCR drug discovery: from virtual screening to polypharmacology.
    Carrieri A; Pérez-Nueno VI; Lentini G; Ritchie DW
    Curr Top Med Chem; 2013; 13(9):1069-97. PubMed ID: 23651484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSARs, data and error in the modern age of drug discovery.
    Kramer C; Lewis R
    Curr Top Med Chem; 2012; 12(17):1896-902. PubMed ID: 23116469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should network biology be used for drug discovery?
    Martínez-Jiménez F; Marti-Renom MA
    Expert Opin Drug Discov; 2016 Dec; 11(12):1135-1137. PubMed ID: 27635856
    [No Abstract]   [Full Text] [Related]  

  • 8. Informing the Selection of Screening Hit Series with in Silico Absorption, Distribution, Metabolism, Excretion, and Toxicity Profiles.
    Sanders JM; Beshore DC; Culberson JC; Fells JI; Imbriglio JE; Gunaydin H; Haidle AM; Labroli M; Mattioni BE; Sciammetta N; Shipe WD; Sheridan RP; Suen LM; Verras A; Walji A; Joshi EM; Bueters T
    J Med Chem; 2017 Aug; 60(16):6771-6780. PubMed ID: 28418656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of computational methods employed in early-stage drug discovery.
    Skjevik AA; Teigen K; Martinez A
    Future Med Chem; 2009 Apr; 1(1):49-63. PubMed ID: 21426070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performing an In Silico Repurposing of Existing Drugs by Combining Virtual Screening and Molecular Dynamics Simulation.
    Sohraby F; Bagheri M; Aryapour H
    Methods Mol Biol; 2019; 1903():23-43. PubMed ID: 30547434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR-Fragment Based Virtual Screening: A Brief Overview.
    Singh M; Tam B; Akabayov B
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29370102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico models in drug development: where we are.
    Piñero J; Furlong LI; Sanz F
    Curr Opin Pharmacol; 2018 Oct; 42():111-121. PubMed ID: 30205360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting potent compounds via model-based global optimization.
    Ahmadi M; Vogt M; Iyer P; Bajorath J; Fröhlich H
    J Chem Inf Model; 2013 Mar; 53(3):553-9. PubMed ID: 23363236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Automatic Quality Control Pipeline for High-Throughput Screening Hit Identification.
    Zhai Y; Chen K; Zhong Y; Zhou B; Ainscow E; Wu YT; Zhou Y
    J Biomol Screen; 2016 Sep; 21(8):832-41. PubMed ID: 27313114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-stoichiometric inhibition in integrated lead finding - a literature review.
    Klumpp M
    Expert Opin Drug Discov; 2016; 11(2):149-62. PubMed ID: 26653534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modern drug discovery technologies: opportunities and challenges in lead discovery.
    Guido RV; Oliva G; Andricopulo AD
    Comb Chem High Throughput Screen; 2011 Dec; 14(10):830-9. PubMed ID: 21843147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico target prediction for elucidating the mode of action of herbicides including prospective validation.
    Chiddarwar RK; Rohrer SG; Wolf A; Tresch S; Wollenhaupt S; Bender A
    J Mol Graph Model; 2017 Jan; 71():70-79. PubMed ID: 27846423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for the discovery and advancement of novel cationic antimicrobial peptides.
    Hadley EB; Hancock RE
    Curr Top Med Chem; 2010; 10(18):1872-81. PubMed ID: 20615190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in developing chemical concepts of genetic phenomena.
    HOROWITZ NH
    Fed Proc; 1956 Jul; 15(2):818-22. PubMed ID: 13356874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.